Browsing: drugs

As a means to reduce future spending, Kane County is removing coverage of weight-loss drugs from its employees’ health insurance plans starting in 2027

July 15, 2026 ByLynne Christensen, Staff Writer

Obesity is recognized as a major global health challenge, with the World Health Organisation (WHO) declaring it a global epidemic

As GLP-1 medications such as Ozempic and Wegovy gain popularity for weight loss, new research suggests they may offer another potential benefit: slowing some of the biological processes associated with ageing

The growing popularity of GLP-1 medications such as Ozempic, Wegovy, and Rybelsus has largely been driven by their ability to help people lose weight, improve blood sugar control, and reduce the risk of cardiovascular disease. Now, researchers have uncovered another possible benefit. A new clinical trial suggests that semaglutide, the active ingredient in those medications,…

GLP-1s are challenging how clinicians and society think about obesity, but weight stigma remains prevalent, said a panel of experts at Health Journalism 2026 in Minneapolis. 

Mounjaro and Zepbound combined for $12.8 billion of Lilly’s $19.8 billion in first-quarter revenue

Some people develop long COVID after a SARS-CoV-2 infection, and people with type 2 diabetes have an especially high risk

JAKARTA – Obesity drugs such as Ozempic and Mounjaro can help lose weight. However, a new study found that most of these drugs have not been shown to significantly improve quality of life after one year of use

Weight‑loss drugs vs bariatric surgery: Who should choose what, experts explain | Mint